Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms.
Tafe
Laura J
LJ
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Garg
Karuna
K
Chew
Ivy
I
Tornos
Carmen
C
Soslow
Robert A
RA
D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000032:analysis / Q000235:genetics; D002277:Carcinoma / Q000737:chemistry / Q000235:genetics / Q000401:mortality / Q000473:pathology* / Q000556:secondary / Q000628:therapy; D018269:Carcinoma, Endometrioid / Q000473:pathology; D002454:Cell Differentiation; D053843:DNA Mismatch Repair; D003937:Diagnosis, Differential; D016889:Endometrial Neoplasms / Q000737:chemistry / Q000235:genetics / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007150:Immunohistochemistry; D008207:Lymphatic Metastasis; D053842:Microsatellite Instability; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000737:chemistry / Q000235:genetics / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D011237:Predictive Value of Tests; D013997:Time Factors; D016896:Treatment Outcome; D055815:Young Adult
D014408:Biomarkers, Tumor